Article
Discovery of genomic loci for liver health and steatosis reveals overlap with glutathione redox genetics
19 Jun 2024
Abstract excerpt
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver condition in the United States, encompassing a wide spectrum of liver pathologies including steatosis, steatohepatitis, fibrosis, and cirrhosis. Despite its high prevalence, there are no medications currently approved by the Food and Drug Administration for the treatment of NAFLD. Recent work has suggested that NAFLD has a strong genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
